Luxury Fertility & Surrogacy Concierge, First-of-Its-Kind.
A new paradigm in which luxury fertility is an experience. Because the world's wealthy don't have time to create their
Globe Newswire27-02-2023, 08:09
Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical development stage, highly selective third generation RXR nuclear receptor agonist compound, supporting its potential use for prevention and treatment of normal 10-07-2024, 07:00
